Global Health Ltd (MEDANTA) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- Global Health Ltd (Medanta) achieved a strong consolidated total income growth of 15% year-on-year in Q2 FY26, reaching 11,089 million, demonstrating robust operational momentum.
- The company marked a significant milestone by commencing operations at its 6th facility, Medanta Noida, a 550-bed state-of-the-art hospital, which became operational in September 2025.
- Medanta is strategically expanding its footprint with plans for a 400+ super specialty hospital in Guwahati and an expanded 750-bed super specialty hospital in Mumbai, following additional FSI approval.
- Profit After Tax (PAT) for the quarter saw a strong 21% year-on-year growth, reaching 1,584 million, with PAT margins improving to 14.2%.
- The company maintains a strong balance sheet with a net cash surplus of 7,182 million at the end of September 2025, providing a solid foundation for ongoing expansion projects.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.